These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 23964564)
1. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents. Mohan S; Eskandari R; Pinto BM Acc Chem Res; 2014 Jan; 47(1):211-25. PubMed ID: 23964564 [TBL] [Abstract][Full Text] [Related]
2. New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. Sim L; Jayakanthan K; Mohan S; Nasi R; Johnston BD; Pinto BM; Rose DR Biochemistry; 2010 Jan; 49(3):443-51. PubMed ID: 20039683 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives. Rossi EJ; Sim L; Kuntz DA; Hahn D; Johnston BD; Ghavami A; Szczepina MG; Kumar NS; Sterchi EE; Nichols BL; Pinto BM; Rose DR FEBS J; 2006 Jun; 273(12):2673-83. PubMed ID: 16817895 [TBL] [Abstract][Full Text] [Related]
4. Probing the intestinal α-glucosidase enzyme specificities of starch-digesting maltase-glucoamylase and sucrase-isomaltase: synthesis and inhibitory properties of 3'- and 5'-maltose-extended de-O-sulfonated ponkoranol. Eskandari R; Jones K; Reddy KR; Jayakanthan K; Chaudet M; Rose DR; Pinto BM Chemistry; 2011 Dec; 17(52):14817-25. PubMed ID: 22127878 [TBL] [Abstract][Full Text] [Related]
5. Mammalian maltase-glucoamylase and sucrase-isomaltase inhibitory effects of Artocarpus heterophyllus: An in vitro and in silico approach. Abdulhaniff P; Sakayanathan P; Loganathan C; Iruthayaraj A; Thiyagarajan R; Thayumanavan P Comput Biol Chem; 2024 Jun; 110():108052. PubMed ID: 38492557 [TBL] [Abstract][Full Text] [Related]
6. Modulation of starch digestion for slow glucose release through "toggling" of activities of mucosal α-glucosidases. Lee BH; Eskandari R; Jones K; Reddy KR; Quezada-Calvillo R; Nichols BL; Rose DR; Hamaker BR; Pinto BM J Biol Chem; 2012 Sep; 287(38):31929-38. PubMed ID: 22851177 [TBL] [Abstract][Full Text] [Related]
7. Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membered ring nitrogen analogue of kotalanol and its de-O-sulfonated derivative. Mohan S; Sim L; Rose DR; Pinto BM Bioorg Med Chem; 2010 Nov; 18(22):7794-8. PubMed ID: 20970346 [TBL] [Abstract][Full Text] [Related]
8. The effect of heteroatom substitution of sulfur for selenium in glucosidase inhibitors on intestinal α-glucosidase activities. Eskandari R; Jones K; Rose DR; Pinto BM Chem Commun (Camb); 2011 Aug; 47(32):9134-6. PubMed ID: 21750824 [TBL] [Abstract][Full Text] [Related]
9. Modeling of cooked starch digestion process using recombinant human pancreatic α-amylase and maltase-glucoamylase for in vitro evaluation of α-glucosidase inhibitors. Cao X; Zhang C; Dong Y; Geng P; Bai F; Bai G Carbohydr Res; 2015 Sep; 414():15-21. PubMed ID: 26162745 [TBL] [Abstract][Full Text] [Related]
10. Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase. Jones K; Sim L; Mohan S; Kumarasamy J; Liu H; Avery S; Naim HY; Quezada-Calvillo R; Nichols BL; Pinto BM; Rose DR Bioorg Med Chem; 2011 Jul; 19(13):3929-34. PubMed ID: 21669536 [TBL] [Abstract][Full Text] [Related]
11. Dietary phenolic compounds selectively inhibit the individual subunits of maltase-glucoamylase and sucrase-isomaltase with the potential of modulating glucose release. Simsek M; Quezada-Calvillo R; Ferruzzi MG; Nichols BL; Hamaker BR J Agric Food Chem; 2015 Apr; 63(15):3873-9. PubMed ID: 25816913 [TBL] [Abstract][Full Text] [Related]
12. Luminal starch substrate "brake" on maltase-glucoamylase activity is located within the glucoamylase subunit. Quezada-Calvillo R; Sim L; Ao Z; Hamaker BR; Quaroni A; Brayer GD; Sterchi EE; Robayo-Torres CC; Rose DR; Nichols BL J Nutr; 2008 Apr; 138(4):685-92. PubMed ID: 18356321 [TBL] [Abstract][Full Text] [Related]
13. Study of the inhibition of two human maltase-glucoamylases catalytic domains by different α-glucosidase inhibitors. Ren L; Cao X; Geng P; Bai F; Bai G Carbohydr Res; 2011 Dec; 346(17):2688-92. PubMed ID: 22036121 [TBL] [Abstract][Full Text] [Related]
14. Towards the elusive structure of kotalanol, a naturally occurring glucosidase inhibitor. Mohan S; Pinto BM Nat Prod Rep; 2010 Apr; 27(4):481-8. PubMed ID: 20336233 [TBL] [Abstract][Full Text] [Related]
15. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. Sim L; Quezada-Calvillo R; Sterchi EE; Nichols BL; Rose DR J Mol Biol; 2008 Jan; 375(3):782-92. PubMed ID: 18036614 [TBL] [Abstract][Full Text] [Related]
16. Maltase-glucoamylase modulates gluconeogenesis and sucrase-isomaltase dominates starch digestion glucogenesis. Diaz-Sotomayor M; Quezada-Calvillo R; Avery SE; Chacko SK; Yan LK; Lin AH; Ao ZH; Hamaker BR; Nichols BL J Pediatr Gastroenterol Nutr; 2013 Dec; 57(6):704-12. PubMed ID: 23838818 [TBL] [Abstract][Full Text] [Related]
17. Studies directed toward the stereochemical structure determination of the naturally occurring glucosidase inhibitor, kotalanol: synthesis and inhibitory activities against human maltase glucoamylase of seven-carbon, chain-extended homologues of salacinol. Nasi R; Patrick BO; Sim L; Rose DR; Pinto BM J Org Chem; 2008 Aug; 73(16):6172-81. PubMed ID: 18651773 [TBL] [Abstract][Full Text] [Related]
18. Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Xie W; Tanabe G; Akaki J; Morikawa T; Ninomiya K; Minematsu T; Yoshikawa M; Wu X; Muraoka O Bioorg Med Chem; 2011 Mar; 19(6):2015-22. PubMed ID: 21345683 [TBL] [Abstract][Full Text] [Related]
19. Selectivity of 3'-O-methylponkoranol for inhibition of N- and C-terminal maltase glucoamylase and sucrase isomaltase, potential therapeutics for digestive disorders or their sequelae. Eskandari R; Jones K; Rose DR; Pinto BM Bioorg Med Chem Lett; 2011 Nov; 21(21):6491-4. PubMed ID: 21924903 [TBL] [Abstract][Full Text] [Related]
20. New chain-extended analogues of salacinol and blintol and their glycosidase inhibitory activities. Mapping the active-site requirements of human maltase glucoamylase. Nasi R; Sim L; Rose DR; Pinto BM J Org Chem; 2007 Jan; 72(1):180-6. PubMed ID: 17194097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]